心脏骤停后神经功能结局的预测:CAST与rCAST评分的前瞻性验证
本研究为前瞻性、多中心、观察性研究,利用日本关东地区(包括东京)的SOS KANTO 2017 OHCA登记数据,外部验证CAST评分(oCAST)及其简化版rCAST评分对接受目标温度管理(TTM)的院外心脏骤停(OHCA)患者神经功能结局的预测价值。共纳入259例恢复自主循环并接受TTM的患者。主要终点为30天良好神经功能结局(CPC评分1或2)。oCAST与rCAST预测30天良好神经功能结局的AUC分别为0.86和0.87,预测90天良好神经功能结局的AUC分别为0.87和0.88。rCAST对神经功能结局的预测准确性高于NULL-PLEASE评分。90天神经功能与rCAST相关(r=0.63,p<0.001)。结论认为rCAST预测准确性高,与oCAST相当,且与90天神经功能强相关,提示其可用于评估心脏骤停后脑损伤严重程度。
要点
- 在接受TTM的OHCA患者中,rCAST预测30天良好神经功能结局的AUC为0.87,oCAST为0.86。
- rCAST预测90天良好神经功能结局的AUC为0.88,oCAST为0.87。
- rCAST对神经功能结局的预测准确性高于NULL-PLEASE评分。
- 90天神经功能与rCAST评分强相关(r=0.63,p<0.001)。
- rCAST评分高的严重组中,神经功能结局良好的患者倾向于入院时低体温且脑CT无灰白质分界消失征象。
适用人群与场景
- 院外心脏骤停(OHCA)后恢复自主循环(ROSC)并接受目标温度管理(TTM)的患者。
诊断标准与关键阈值
- 良好神经功能结局定义为30天或90天脑功能分类(CPC)评分为1或2。
研究设计与关键结果
- 研究类型为前瞻性、多中心、观察性研究,使用SOS KANTO 2017登记数据,纳入259例ROSC后接受TTM的OHCA患者。
- 主要终点30天良好神经功能结局:oCAST的AUC为0.86,rCAST的AUC为0.87。
- 次要终点90天良好神经功能结局:oCAST的AUC为0.87,rCAST的AUC为0.88。
- rCAST对神经功能结局的预测准确性高于NULL-PLEASE评分。
- rCAST分类为高严重度组且神经功能结局良好的患者,倾向于入院时低体温且脑CT无灰白质分界消失征象。
- 90天神经功能与rCAST相关(r=0.63,p<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性、多中心、观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- rCAST评分可用于评估接受TTM的OHCA患者心脏骤停后脑损伤严重程度并预测神经功能结局,其预测准确性高且与oCAST相当。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The neurologic prognosis of out-of-hospital cardiac arrest (OHCA) patients in whom return of spontaneous circulation (ROSC) is achieved remains poor. The aim of this study was to externally and prospectively validate two scoring systems developed by us: the CAST score, a scoring system to predict the neurological prognosis of OHCA patients undergoing targeted temperature management (TTM), and a simplified version of the same score developed for improved ease of use in clinical settings, the revised CAST (rCAST) score.
METHODS: This study was a prospective, multicenter, observational study conducted using the SOS KANTO 2017 registry, an OHCA registry involving hospitals in the Kanto region (including Tokyo) of Japan. The primary outcome was favorable neurological outcome (defined as Cerebral Performance Category score of 1 or 2) at 30 days and the secondary outcomes were favorable neurological outcome at 90 days and survival at 30 and 90 days. The predictive accuracies of the original CAST (oCAST) and rCAST scores were evaluated by using area under the receiver operating characteristic curve (AUC).
RESULTS: Of 9909 OHCA patients, 565 showed ROSC and received TTM. Of these, we analyzed the data of 259 patients in this study. The areas under the receiver operating characteristic curve (AUCs) of the oCAST and rCAST scores for predicting a favorable neurological outcome at 30 days were 0.86 and 0.87, respectively, and those for predicting a favorable neurological outcome at 90 days were 0.87 and 0.88, respectively. The rCAST showed a higher predictive accuracy for the neurological outcome as compared with the NULL-PLEASE score. The patients with a favorable neurological outcome who had been classified into the high severity group based on the rCAST tended to have hypothermia at hospital arrival and to not show any signs of loss of gray-white matter differentiation on brain CT. Neurological function at 90 days was correlated with the rCAST (r = 0.63, p < 0.001).
CONCLUSIONS: rCAST showed high predictive accuracy for the neurological prognosis of OHCA patients managed by TTM, comparable to that of the oCAST score. The scores on the rCAST were strongly correlated with the neurological functions at 90 days, implying that the rCAST is a useful scale for assessing the severity of brain injury after cardiac arrest.
参考来源
- Kikutani K, Nishikimi M, Matsui K, et al. Prediction of the neurological outcomes post-cardiac arrest: A prospective validation of the CAST and rCAST. Am J Emerg Med. 2023. PMID: 38149972. doi:10.1016/j.ajem.2023.10.028
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。